Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa
Clinical trial NCT02391415 · COMPLETED
Trial details
- NCT number
- NCT02391415
- Sponsor
- Serum Institute of India Pvt. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-11-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.